Bisantrene solubility and skin toxicity studies: Efficacy of sodium bicarbonate as a local ulceration antidote Robert T. DorrYei-Mei PengDavid S. Alberts OriginalPaper Pages: 351 - 357
Menogaril: a new anthracycline agent entering clinical trials J. Patrick McGovrenKenneth G. NelsonJohn P. Christopher OriginalPaper Pages: 359 - 367
Phase I trial of 4′-deoxydoxorubicin given weekly C. SessaL. BosiaF. Cavalli OriginalPaper Pages: 369 - 374
Phase I trial of Idarubicin (4-demethoxydaunorubicin) in adult acute leukemia M. HayatP. HurteloupD. Kamioner OriginalPaper Pages: 375 - 379
Phase I study of 7-N-(p-hydroxyphenyl)-mitomycin C Sadayasu MeguroTakaki NagataMakoto Ogawa OriginalPaper Pages: 381 - 385
Five-day schedule of vinzolidine, an oral vinca alkaloid, in a variety of tumors Bonnie J. TakasugiAurelia B. RobertoneDavid S. Alberts OriginalPaper Pages: 387 - 390
5-Fluorouracil and Folinic Acid: a Phase I–II trial in gastrointestinal malignancy James CunninghamR. M. BukowskiJ. Purvis OriginalPaper Pages: 391 - 395
Phase II trial of 4′-epi-doxorubicin in metastatic colorectal carcinoma J. A. Wils OriginalPaper Pages: 397 - 399
Chlorozotocin: results in colorectal carcinoma treated with high and low doses Charles D. HaasJoseph D. McCrackenHarmon J. Eyre OriginalPaper Pages: 401 - 404
Southwest Oncology Group study of Mitoxantrone for treatment of patients with advanced squamous cell carcinoma of the head and neck Douglas E. MattoxGary M. ClarkWalter J. Stuckey OriginalPaper Pages: 405 - 407
Advantages of integrated trials for performing multiple Phase II studies Gary B. WeissJames A. Hokanson OriginalPaper Pages: 409 - 414